Literature DB >> 3003906

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency.

T Folks, D M Powell, M M Lightfoote, S Benn, M A Martin, A S Fauci.   

Abstract

When the human T-cell line A3.01 is infected with HTLV-III/LAV, the virus associated with the acquired immune deficiency syndrome (AIDS), most of the cells are killed. However, a small number of cells that lack the Leu-3 surface marker survive. Under normal conditions these surviving cells do not produce virus, nor can they be infected by the virus, but they can be induced to produce virus by treatment with 5-iodo-2'-deoxyuridine. This response can be induced for as long as 3 months after the initial infection, suggesting that the cells may harbor a latent form of HTLV-III/LAV.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003906     DOI: 10.1126/science.3003906

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  79 in total

1.  Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.

Authors:  J A Mikovits; N C Lohrey; R Schulof; J Courtless; F W Ruscetti
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 2.  HIV latency.

Authors:  Robert F Siliciano; Warner C Greene
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

3.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

4.  The regulatory mechanisms of human immunodeficiency virus replication predict multiple expression rates.

Authors:  B O Palsson; J D Keasling; S G Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.

Authors:  Victoria E K Walker-Sperling; Valerie J Cohen; Patrick M Tarwater; Joel N Blankson
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

6.  A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activity.

Authors:  T Hoover; J Mikovits; D Court; Y L Liu; H F Kung
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

7.  Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.

Authors:  H C Lin; M Bodkin; R B Lal; A B Rabson
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.

Authors:  P Bérubé; B Barbeau; R Cantin; R P Sékaly; M Tremblay
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.

Authors:  T M Niederman; J V Garcia; W R Hastings; S Luria; L Ratner
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity.

Authors:  Sonia Gauthier; Isabelle Pelletier; Michel Ouellet; Amandine Vargas; Michel J Tremblay; Sachiko Sato; Benoit Barbeau
Journal:  Retrovirology       Date:  2008-11-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.